Evidence map›Paper›PMID 39080084›Full record

ArticleCellular and molecular life sciences : CMLS2024

The cellular adaptor GULP1 interacts with ATG14 to potentiate autophagy and APP processing.

Dennis Dik-Long Chau, Zhicheng Yu, Wai Wa Ray Chan, Zhai Yuqi, Raymond Chuen Chung Chang, Jacky Chi Ki Ngo, Ho Yin Edwin Chan, Kwok-Fai Lau

Abstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. The ATG14: multi-layer autophagy control and an emerging therapeutic target in cancer.Apoptosis : an international journal on programmed cell death · 2026
    Review
  2. Article
  3. Molecular mechanism on autophagy associated cardiovascular dysfunction inFrontiers in cell and developmental biology · 2025
    Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Dennis Dik-Long ChauSchool of Life Sciences, Faculty of Science, The Chinese University of Hong Kong, Hong Kong SAR, China.
Zhicheng YuSchool of Life Sciences, Faculty of Science, The Chinese University of Hong Kong, Hong Kong SAR, China.
Wai Wa Ray ChanSchool of Life Sciences, Faculty of Science, The Chinese University of Hong Kong, Hong Kong SAR, China.ORCID http://orcid.org/0000-0002-3735-1985
Zhai YuqiSchool of Life Sciences, Faculty of Science, The Chinese University of Hong Kong, Hong Kong SAR, China.
Raymond Chuen Chung ChangLaboratory of Neurodegenerative Diseases, School of Biomedical Sciences, LKS Faculty of Medicine, and State Key Laboratory of Brain and Cognitive Sciences, The University of Hong Kong, Hong Kong SAR, China.
Jacky Chi Ki NgoSchool of Life Sciences, Faculty of Science, The Chinese University of Hong Kong, Hong Kong SAR, China.
Ho Yin Edwin ChanSchool of Life Sciences, Faculty of Science, The Chinese University of Hong Kong, Hong Kong SAR, China.
Kwok-Fai LauSchool of Life Sciences, Faculty of Science, The Chinese University of Hong Kong, Hong Kong SAR, China. kflau@cuhk.edu.hk.ORCID http://orcid.org/0000-0002-0193-1152

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autophagy is a highly conserved catabolic mechanism by which unnecessary or dysfunctional cellular components are removed. The dysregulation of autophagy has been implicated in various neurodegenerative diseases, including Alzheimer's disease (AD). Understanding the molecular mechanism(s)/molecules that influence autophagy may provide important insights into developing therapeutic strategies against AD and other neurodegenerative disorders. Engulfment adaptor phosphotyrosine-binding domain-containing protein 1 (GULP1) is an adaptor that interacts with amyloid precursor protein (APP) to promote amyloid-β peptide production via an unidentified mechanism. Emerging evidence suggests that GULP1 has a role in autophagy. Here, we show that GULP1 is involved in autophagy through an interaction with autophagy-related 14 (ATG14), which is a regulator of autophagosome formation. GULP1 potentiated the stimulatory effect of ATG14 on autophagy by modulating class III phosphatidylinositol 3-kinase complex 1 (PI3KC3-C1) activity. The effect of GULP1 is attenuated by a GULP1 mutation (GULP1m) that disrupts the GULP1-ATG14 interaction. Conversely, PI3KC3-C1 activity is enhanced in cells expressing APP but not in those expressing an APP mutant that does not bind GULP1, which suggests a role of GULP1-APP in regulating PI3KC3-C1 activity. Notably, GULP1 facilitates the targeting of ATG14 to the endoplasmic reticulum (ER). Moreover, the levels of both ATG14 and APP are elevated in the autophagic vacuoles (AVs) of cells expressing GULP1, but not in those expressing GULP1m. APP processing is markedly enhanced in cells co-expressing GULP1 and ATG14. Hence, GULP1 alters APP processing by promoting the entry of APP into AVs. In summary, we unveil a novel role of GULP1 in enhancing the targeting of ATG14 to the ER to stimulate autophagy and, consequently, APP processing.

Indexed as

Adaptor Proteins, Signal TransducingAmyloid beta-Protein PrecursorAutophagyAutophagy-Related ProteinsAdaptor Proteins, Vesicular TransportAlzheimer DiseaseClass III Phosphatidylinositol 3-KinasesHEK293 CellsHumansProtein BindingVesicular Transport ProteinsAdaptor Proteins, Signal TransducingAdaptor Proteins, Vesicular TransportAmyloid beta-Protein PrecursorATG14 protein, humanAutophagy-Related ProteinsClass III Phosphatidylinositol 3-KinasesGULP1 protein, humanVesicular Transport ProteinsAmyloid precursor proteinAutophagy-related 14GULP1LC3Macroautophagy

Identifiers

PMID39080084
PMCPMC11335243

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.